Your browser doesn't support javascript.
loading
Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients.
Eissa, Eman; Morcos, Botros; Dorgham, Dalia; Kholoussi, Naglaa.
Afiliação
  • Eissa E; Department of Immunogenetics, National Research Centre, Cairo, Egypt.
  • Morcos B; Department of Immunogenetics, National Research Centre, Cairo, Egypt.
  • Dorgham D; Department of Rheumatology and Rehabilitation, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Kholoussi N; Department of Immunogenetics, National Research Centre, Cairo, Egypt.
Arch Rheumatol ; 37(3): 417-423, 2022 Sep.
Article em En | MEDLINE | ID: mdl-36589613
ABSTRACT

Objectives:

This study aims to evaluate the expression pattern of factor H in peripheral blood and the frequency of factor H autoantibodies in plasma of juvenile-onset systemic lupus erythematosus (jSLE) patients compared to healthy controls. Patients and

methods:

Between March 2019 and October 2019, a total of 30 healthy individuals (3 males, 27 females; mean age 26±7.4 years; range, 18 to 40 years) and 65 jSLE patients (age of onset ≤16 years) (2 males, 63 females; mean age 23.4±7 years; range, 15 to 38 years) were included. Factor H expression pattern was examined in blood of all subjects using quantitative real-time polymerase chain reaction and the frequency of factor H autoantibodies was estimated in plasma using enzyme-linked immunosorbent assay.

Results:

Factor H expression was significantly downregulated in jSLE patients compared to healthy controls (p<0.01). A significant underexpression of factor H was observed in jSLE patients with nephritis compared to those without nephritis (p<0.03), while there was no association of factor H expression levels with any of the other clinical and serological features, disease activity or disease damage index of patients. Only 5% of jSLE patients were positive for factor H autoantibodies without any correlations with the clinical data or disease activity of patients.

Conclusion:

Our study results suggest that factor H expression can be dysregulated in jSLE patients.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Arch Rheumatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Egito

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Arch Rheumatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Egito